Dr. Patrick Soon-Shiong

speaker

969 appearances 7 recordings 4 series first heard Nov 2024 last heard 9 Oct

Dr. Patrick Soon-Shiong’s voice in public audio — every appearance, attributed to the second.

Trend

recordings per month · last 12 months

Recordings per month over the last 12 months — 1 in all, peaking in Oct 2025 with 1.

newest first · ▶ plays the moment

The review process took two and a half years.

It just got approved in April 2024.

This is why I said this president, you and I talked about it, in his presidency could inform the world and the FDA

That there's a breakthrough for tumor types.

It's like if you have anemia, do you get a blood transfusion?

Do you ask, have you lost blood because you have breast cancer?

You need blood.

Does your body need natural killer cells and T-cells regardless of the tumor type?

Especially since we've done this in every tumor type.

It is not possible to do randomized trial in lung cancer, which, by the way, we have now started.

So I resorted to, if you go to csifm.org or .com, you will see the trials that I'm now open as randomized trials.

So we're now taking patients with lung cancer who failed everything.

CSS, which is Chan Sun Chung, CSS, IFM, which is the Institute for Molecular Medicine, .com or .org.

It's our clinic.

And so we've taken patients now as a request who have failed second line, third line lung cancer, failed chemo, failed radiation, failed checkpoints.

And we showed when we give that the same checkpoint while you're progressing, our Antivo, our BioShield, we've tripled the survival.

Because the moment you have chemo, the moment you have radiation, guess what it does?

It wipes out your NK cells and T cells.

Mm-hmm.

We've been trained, as I just said in this forward, to have a short-term gain thinking the tumor goes down.

Showing 321–340 of 969 · page 17 of 49